Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Small Cell Lung Carcinoma × osimertinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Lung Neoplasms 6 Small Cell Lung Carcinoma 1 Resectable Non-small Cell Lung Cancer 1 Recurrence 1 Rare Tumour 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 NSCLC 1 Meningeal Carcinomatosis 1 Brain Neoplasms 1

Interventions

Etoposide 13 Carboplatin 11 Drug Therapy 6 Cisplatin 6 anlotinib 5 Radiotherapy 5 PM 01183 5 toripalimab 4 durvalumab 4 atezolizumab 4 Platinum 4 irinotecan sucrosofate 3 tislelizumab 2 famitinib 2 apatinib 2 Topotecan 2 Pemetrexed 2 Paclitaxel 2 Injections 2 tremelimumab 1 surufatinib 1 sacituzumab govitecan 1 osimertinib 1 amrubicin 1 Tomography, X-Ray Computed 1 Radiation Dose Hypofractionation 1 Rabeprazole 1 Proton Pump Inhibitors 1 Platinum Compounds 1 Penfluridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07153055 2025-12-18

LOTS

Indiana University

Phase 1/2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡